Following Harbour BioMed?

Get the free weekly executive digest

The latest leadership moves, like Harbour BioMed’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Harbour Bio Med Appoints Dr. Jenny Xie As Chief Scientific Officer, Immunology

PRIVATEMar 19, 2026•3 months ago

Position

Chief Scientific Officer

Company

Harbour BioMed

Jenny Xie

CambridgeBiotechnologyTherapeuticsBiopharma

Description

Harbour BioMed has announced the appointment of Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation. Dr

Company Information

Company

Harbour BioMed

Location

Cambridge, Massachusetts, United States

About

Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on immunology and oncology. The company is building its robust portfolio and differentiated pipeline through internal R&D capability, collaborations with co-discovery and co-development partners, and select acquisitions.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Harbour BioMed's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months